Sanatorium profesora Arenbergera

The Sanatorium profesora Arenbergera’s dermatology department advances research on immune‑mediated conditions such as Chronic Spontaneous Urticaria and Psoriatic Arthritis. Trials primarily evaluate long‑term safety of biologic agents and measure clinical improvement with standardized activity scores.

• Long‑term safety monitoring of biologic therapies
• Reduction of urticaria activity using weekly scores
• Assessment of patient‑reported outcomes
• Comparison of active treatment versus placebo

With two ongoing studies and a single dedicated investigator, the site in Prague provides patients access to cutting‑edge evaluation of new immune‑targeted treatments.

In the field of Skin and Connective Tissue Diseases, the centre focuses on severe inflammatory skin conditions including Severe Chronic Plaque Psoriasis and related musculoskeletal disorders such as Ankylosing Spondylitis. The purpose of the studies is to determine therapeutic effectiveness and safety for patients with persistent plaque psoriasis and axial spondyloarthritis.

• Evaluation of plaque psoriasis treatment effectiveness
• Therapeutic assessment for ankylosing spondylitis and axial spondyloarthritis
• Continuation studies for patients previously on Secukinumab
• Placebo‑controlled efficacy investigations

Conducted at the Prague facility, these trials offer participants the opportunity to contribute to the development of improved skin‑focused therapies.